KP

Krishna Polu

CEO Commit Biologics

San Francisco Bay Area

Invests in

Stages:

  • Min Investment:

    $100,000.00
  • Max Investment:

    $5,000,000.00
  • Target Investment:

    $1,500,000.00

Work Experience

  • Steering Committee Member, Venture Philanthropy

    2024

  • Chief Executive Officer

    2023

2023 - 2023

  • Director Board of Directors

    2023 - 2023

2022 - 2023

  • Director Board of Directors

    2022 - 2023

  • Principal

    2020 - 2023

  • Director Board of Directors

    2020 - 2022

    Successful De-SPAC combo with New Amsterdam Pharma (NASDAQ:NAMS)

2018 - 2021

  • EVP of R&D and Chief Medical Officer

    2018 - 2021

2018 - 2018

  • Interim CEO

    2018 - 2018

    Scout Bio, Inc., a newly-formed development-stage biotechnology company focused on the discovery and development of vector-delivered protein and monoclonal antibody therapeutics for animal health. https://www.scoutbio.co/

  • Entrepreneur In Residence

    2017 - 2018

    CEO and Founder of Expedition Therapeutics, a Frazier Healthcare search company focused on identifying and in-licensing assets in the kidney, metabolic, and inflammatory therapeutic areas.

  • Chief Medical Officer

    2015 - 2016

    Acquired by Horizon Pharmaceuticals.